Alpha Tau Medical Ltd. (DRTSW)
USD 0.21
(12.64%)
USD 0.21
(12.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -17.95 Million | -23.87 Million | -11.81 Million | -7.25 Million | -6.91 Million |
| Net Income | -29.15 Million | -33.76 Million | -27.27 Million | -8.88 Million | -8.46 Million |
| Depreciation & Amortization | 1.07 Million | 979 Thousand | 776 Thousand | 86 Thousand | 66 Thousand |
| Deferred income taxes | -8.93 Million | - | 13.25 Million | 203 Thousand | 994 Thousand |
| Stock-based compensation | 7.92 Million | 6.74 Million | 812 Thousand | 596 Thousand | 546 Thousand |
| Change in working capital | 2.49 Million | -307 Thousand | 585 Thousand | 899 Thousand | -64 Thousand |
| Other non-cash items | 8.63 Million | 2.46 Million | 29 Thousand | -153 Thousand | 12 Thousand |
| Investing Cash Flow | 18.68 Million | -89.93 Million | 19.27 Million | -7.81 Million | -10.16 Million |
| Investments in PPE | -6.4 Million | -904 Thousand | -2.92 Million | -3.76 Million | -1.29 Million |
| Acquisitions | -28.23 Million | -22.2 Million | -22.2 Million | - | 8870.00 |
| Investment purchases | -163.62 Million | -121.13 Million | -8.08 Million | -4.05 Million | -54.27 Million |
| Sales/Maturities of investments | 191.86 Million | 32.1 Million | 30.28 Million | 66.15 Million | 45.4 Million |
| Other Investing Activities | 25.08 Million | 22.2 Million | 22.2 Million | -66.15 Million | -8870.00 |
| Financing Cash Flow | 5.29 Million | 96.9 Million | 111 Thousand | 29.31 Million | 5.32 Million |
| Debt repayment | -5248.00 | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 49 Thousand | 3.36 Million | 111 Thousand | 29.31 Million | 5.25 Million |
| Other Financing Activities | 5.24 Million | 93.54 Million | 111.00 | 29.31 Thousand | 73 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 1.14 Million | 220 Thousand | 239 Thousand | 114 Thousand | 148 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 1.34 Million | -527 Thousand | 346 Thousand | 785 Thousand | -212 Thousand |
| Cash at beginning of period | 6.68 Million | 23.85 Million | 16.17 Million | 1.84 Million | 13.6 Million |
| Cash at end of period | 15.8 Million | 6.68 Million | 23.85 Million | 16.17 Million | 1.84 Million |
| Capital Expenditure | -6.4 Million | -904 Thousand | -2.92 Million | -3.76 Million | -1.29 Million |
| Effect of forex changes on cash | -50 Thousand | -258 Thousand | 108 Thousand | 84 Thousand | -18 Thousand |
| Net cash flow / Change in cash | 9.12 Million | -17.16 Million | 7.68 Million | 14.33 Million | -11.76 Million |
| Free Cash Flow | -24.35 Million | -24.78 Million | -14.73 Million | -11.01 Million | -8.2 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.36 Million | -7.98 Million | -7.36 Million | -29.15 Million | -4.91 Million | -8.69 Million |
| Depreciation & Amortization | - | - | - | 1.07 Million | - | 512 Thousand |
| Deferred income taxes | - | - | - | -8.93 Million | - | - |
| Stock-based compensation | 4.86 Million | - | 7.92 Million | 7.92 Million | -3.78 Million | 3.78 Million |
| Change in working capital | - | - | - | 2.49 Million | - | - |
| Other non-cash items | 2.5 Million | 7.98 Million | -561 Thousand | 8.63 Million | 8.69 Million | 4.9 Million |
| Investing Cash Flow | - | - | - | 18.68 Million | - | - |
| Investments in PPE | - | - | - | -6.4 Million | - | - |
| Acquisitions | - | - | - | -28.23 Million | - | - |
| Investment purchases | - | - | - | -163.62 Million | - | - |
| Sales/Maturities of investments | - | - | - | 191.86 Million | - | - |
| Other Investing Activities | - | - | - | 25.08 Million | - | - |
| Financing Cash Flow | - | - | - | 5.29 Million | - | - |
| Debt repayment | - | - | - | -5248.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 49 Thousand | - | - |
| Other Financing Activities | - | - | - | 5.24 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | 1.14 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | 1.34 Million | - | - |
| Cash at beginning of period | - | - | - | 6.68 Million | 1.68 Million | 1.73 Million |
| Cash at end of period | - | - | - | 15.8 Million | 2.96 Million | 1.68 Million |
| Capital Expenditure | - | - | - | -6.4 Million | - | - |
| Effect of forex changes on cash | - | - | - | -50 Thousand | - | - |
| Net cash flow / Change in cash | - | - | - | 9.12 Million | 1.27 Million | -50 Thousand |
| Free Cash Flow | - | - | - | -24.35 Million | -3784.00 | 3784.00 |
MMMW
PYXS
I3E
002888
TECK-A
TECK-B